Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
NCT04910295
·
clinicaltrials.gov ↗
COMPLETED
Status
112
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Covid19
Interventions
DRUG:
COVID-19 vaccine
Sponsor
Seoul National University Hospital